Extraction and visual comparison of tumour tissues
By administering the ingredients for the drug, along with the transition-metal catalyst, cancer growth was inhibited (bottom)
An international research group at the RIKEN Cluster for Pioneering Research (CPR) has successfully treated cancer in mice using metal catalysts that assemble anticancer drugs together inside the body. Published in the scientific journal Nature Communications, the study is the first report of therapeutic in vivo synthetic chemistry being used to make anticancer substances where they are needed simply by injecting their ingredients through a vein. Because this technique avoids indiscriminate tissue damage, it is expected to have a significant impact on cancer treatment.
Aside from effectiveness at killing cancer cells, a major challenge to cancer chemotherapy is how to mitigate the toxic side effects on the body. Drugs that can damage cancer cells can damage non-cancerous cells as well, and the negative side effects of chemotherapy can cause permanent and debilitating damage. Current methods for reducing these side effects include selective delivery of anticancer drugs to cancer tissue (drug delivery) and conversion of non-toxic compounds (prodrugs) into toxic compounds nearby the cancerous tissue.
Katsunori Tanaka at RIKEN CPR, who led the new study, has developed a method for activating prodrugs using transition-metal catalysis inside the body. When the catalyst is injected into an organism, it usually has no effect because it is destroyed by antioxidants such as glutathione. By placing the transition-metal catalysts inside special pockets within a protein, Tanaka and his colleagues have been able to avoid this problem and stabilize the catalytic function in vivo, thus ensuring that the chemical reaction can proceed efficiently in the body. For this technique to work, the catalyst needs to selectively find its way to the cancer. As in their previous studies, the team targeted the catalyst to the cancer by attaching chains of cancer-binding sugar molecules to the surface of the carrier protein. Using these techniques, Tanaka’s group succeeded in inhibiting cancer growth and metastasis, as well as reducing the side effects. The new study is a proof of concept in which cancer in mice was treated by actually assembling anticancer drugs inside the body near the cancer cells. “In the past, we used similar methods to attach anticancer drugs to tumors,” says Tanaka, “but here, we were able to avoid putting any toxic drugs into the body at all.”
Noting that the basic skeleton of most anticancer drugs contains a benzene ring, the researchers started by making benzene rings inside the body using transition-metal catalysts. “No one believed that artificially synthesizing benzene rings inside the body was possible, but I was confident that we could do it based on our previous achievements,” says Tanaka. Using a transition metal-catalyzed complex designed for selective delivery to cancerous tissues, they succeeded in efficiently creating the benzene-rings needed by cancer drugs in the vicinity of cancer cells. By using non-toxic substances, and only joining them together to form active anticancer drugs at the tumor site, they saw a 1000-times increase in the cancer-inhibiting activity of the drugs. Simply administering the ingredients needed for the drug, along with the transition-metal catalyst, through a vein, cancer growth was inhibited without side effects such as weight loss.
This is the first time that active anticancer drugs have been assembled on-site and effectively combatted cancer by simply injecting the ingredients for the drug through a vein. In addition to benzene, the methodology developed in this study is expected to enable a variety of other molecules to be synthesized inside the body. The hope is that this type of chemotherapy will become a useful therapeutic platform for the future of cancer treatment.
“Many patients with cancer are dying because of the side effects of treatment. We believe our technology, which attacks cancer cells highly effectively without side effects, will be able to save lives,” says Tanaka. “The method will also allow us to reconsider using compounds that have not been used before because they were too toxic when delivered to the whole body. Now they can be synthesized at the tumor site without affecting healthy tissue. We believe this is a paradigm shift for pharmaceuticals and drug discovery.”
Original Article: Cancer therapy using on-site synthesis of anticancer drugs
More from: RIKEN
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Assembling anticancer drugs inside the body
- How personalized medicine is transforming your health care
Twelve years after Teresa McKeown beat stage 3 breast cancer with a brutal regimen of chemotherapy ... drugs for each patient based on the tumor profile, not based on a part of the body or based ...
- The Future of Antibody-Drug Conjugates in Lung Cancer Treatment
Drs Jacob Sands and Benjamin P. Levy discuss antibody-drug conjugates in lung cancer treatment, including differences in efficacy, toxicity profiles, and what the future holds.
- Body found inside home in South Deering neighborhood: police
A body was discovered Saturday afternoon inside a townhouse in the South Deering neighborhood on the city’s South Side, according to Chicago police. Authorities did not indicate an apparent ...
- New Cancer 'Missile' Drugs May Be More Effective Than Traditional Chemotherapy
Antibody-drug conjugates are a new type of cancer therapy that deliver cancer-killing medicine to cancer cells, avoiding healthy cells along the way.
- Recreational drugs and what they do to your body
After using the drug people often feel tired, depressed and hungry. Ecstasy affects body temperature control. Dancing for long periods in a hot atmosphere increases the risk of users overheating ...
Go deeper with Google Headlines on:
Assembling anticancer drugs inside the body
[google_news title=”” keyword=”assembling anticancer drugs inside the body” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Negative side effects of chemotherapy
- Tests could lead to fewer people having unnecessary chemotherapy after surgery for early breast cancer
If tumour profiling test results indicate that a person is at low risk of cancer recurrence, they may feel more comfortable making the decision to forego chemotherapy. Fewer people having unnecessary ...
- Breast cancer sufferers could avoid chemotherapy through tumour profiling
but for others they will not have to face the side-effects which come with the treatment.” Tumour profiling tests are already recommended for guiding chemotherapy decisions in people with oestrogen ...
- 5 best care packages for someone going through chemotherapy
When chemotherapy side effects set in, physical discomfort can be significant. A comfort care package should include items that alleviate these physical pains and aches. Soft, loose clothing made from ...
- Side Effects of Herceptin: What You Need to Know
In studies, people who used Herceptin with chemotherapy (traditional drugs used to treat cancer) were more likely to have mild side effects compared with people who used Herceptin alone.
- 12 Chemotherapy Tips and Tricks from a Survivor
The side effects of chemotherapy will be different ... Also, it allowed my body to process the toxins from the chemotherapy with fewer negative impacts. My advice is simply to eat whenever you ...
Go deeper with Google Headlines on:
Negative side effects of chemotherapy
[google_news title=”” keyword=”negative side effects of chemotherapy” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]